Resmed Insider Sold Shares Worth $1,090,771, According to a Recent SEC Filing

Michael J. Farrell, Director, Chairman and Chief Executive Officer, on July 07, 2026, sold 4,991 shares in Resmed (RMD) for $1,090,771. Following the Form 4 filing with the SEC, Farrell has control over a total of 468,313 common shares of the company, with 466,223 shares held directly and 2,090 controlled indirectly. SEC Filing: